The Most-Favored-Nation Policy: Outlook and Implications
President Trump signed an Executive Order to implement a "Most Favored Nation (MFN)" drug pricing approach, aiming to lower U.S. prescription drug costs by tying prices to those in similarly developed countries.
The MFN Executive Order has the broadest and strictest scope compared to previous attempts at implementing International Reference Pricing-based methodology.
President Trump’s latest attempt at implementing International Reference Pricing-based methodology to regulate drug prices in the US has the broadest and strictest scope.
The article provides an overview of the MFN Executive Order, initial industry response, and hypothesizes its implications on global pricing and market access.
Author's Summary
President Trump's MFN policy aims to lower US drug prices by referencing international prices.
- MFN Executive Order signed on May 12th, 2025
- Aims to lower US prescription drug costs
- Ties prices to those in similarly developed countries
More News
- The first week of testimony in Brian Walshe’s murder trial is over. Here are takeaways from Day 5
- Netanyahu: Won’t quit politics for pardon in corruption trial
- Is London The Top City In The World For This Cuisine? These Chefs Say Yes
- Solidarity on Trial in Greece
- Restaurants, hôtels, bars, caves et commerces de … - Paris
- Spillcontrol – Spill Control
- Golden State Warriors vs Cleveland Cavaliers regular season game: Full injury report, who's out, and more
- Over 4,000 gallons of oil and toxic wastewater spill in San Ardo
- Where the Chefs Eat: Skye McAlpine’s Venice
- CHEFS (@chefs_podcast) - Instagram photos and videos